Viewing Study NCT01621256


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-01-05 @ 2:51 AM
Study NCT ID: NCT01621256
Status: COMPLETED
Last Update Posted: 2018-12-21
First Post: 2012-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Sponsor: Nordmark Arzneimittel GmbH & Co. KG
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NM-V-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None INDUSTRY View